Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

  • 1 of 1

Researchers conclude that, although ZMapp appeared beneficial as a treatment against Ebola, the result did not meet a prespecified statistical threshold for efficacy, potentially due to inadequate trial recruitment

ZMapp appeared beneficial as a treatment against Ebola (virus pictured budding from cell) in an open-label trial but the result did not meet a prespecified statistical threshold for efficacy, potentially due to inadequate trial recruitment

Source  National Institute of Allergy and Infectious Diseases (NIAID)